Added to YB: 2024-07-08
Pitch date: 2024-07-05
MOB.ST [bullish]
Moberg Pharma AB (publ)
-74.99%
current return
Author Info
H Capital is an M&A Consultant who writes about cheap, high potential stocks. Sign up for the newsletter.
Company Info
Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden.
Market Cap
SEK 448.5M
Pitch Price
SEK 34.50
Price Target
N/A
Dividend
N/A
EV/EBITDA
-6.33
P/E
-17.42
EV/Sales
16.30
Sector
Pharmaceuticals
Category
growth
Why I believe my portfolio will outperform over the next 5 years: Moberg Pharma AB
MOB.ST: Revolutionary nail fungus drug MOB-015 dominating market 1.5 months post-launch, expanding market 52%. Cash-generative biz w/ multibagger potential. Market underestimates impact. Rare opportunity to invest in micro-cap disrupting billion-dollar market. High risk/reward. Success hinges on MOB-015 performance. Similar thesis to Cipher Pharma.
Read full article (2 min)